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We consider a cohort of 1 189 male German factory workers (production period 1952-1984) who
produced phenoxy herbicides and were exposed to dioxins. Follow-up until the end of 1992
yielded a significantly increased standardized mortality ratio (SMR) fortotal cancer (SMR 141; 95%
confidence interval 117-168). 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) concentrations up to
2252 ng/kg body fat were measured in 275 cohort members. Other higher chlorinated dioxins and
furans also occurred in high concentrations. For quantitative analysis, the integrated TCDD
concentration over time was used as an exposure variable, which was calculated using results
from half-life estimation for TCDD and workplace history data. The other congeners were
expressed as toxic equivalency (TEQ) and compared to TCDD using international toxic equivalency
factors. Poisson and Cox regressions were used to investigate dose-response relationships.
Various covariables (e.g., exposure to f-hexachlorocyclohexane, employment characteristics) were
considered. In all analyses, TCDD and TEQ exposures were related to total cancer mortality. The
power model yielded a relative risk (RR) function RR(xI= (1 +0.17x)0326 for TCDD (in
microgram/kilogram blood fatxyears)-only a slightly better fit than a linear RR function-and
RR() =(1 +0.023X0.795 for TEQ. Investigations on latency did not show strong effects. Different
methods were applied to investigate the robustness of the results and yielded almost identical
results. The results were used for unit risk estimation. Taking into account different sources of
variation, an interval of 103 to 10-2 forthe additional lifetime cancer risk under a daily intake of 1 pg
TCDD/kg body weight/day was estimated from the dose-response models considered.
Uncertainties regarding the dose-response function remain. These data did not indicate the
existence of a threshold value; however, such a value cannot be excluded with any certainty.
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Introduction
The most toxic dioxin congener, 2,3,7,8- registry of persons occupationally exposed
tetrachlorodibenzo-p-dioxin (TCDD), was to phenoxy herbicides and contaminants
a contaminant in the production of (TCDD and other higher chlorinated
phenoxy herbicides such as 2,4,5-trichloro- dibenzodioxins and -furans). The studies
phenoxyacetic acid (2,4,5-T) and its deriv- showed a rather consistent picture of an
atives. Cohorts ofworkers occupationally increased cancer risk for all sites ifcohorts
exposed to TCDD have been studied with verified high exposures to TCDD are
extensively (1-4). Kogevinas et al. (5) considered. However, the picture is not as
report results from a large international clear ifthe focus is on specific cancer sites.
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The International Agency for Research on
Cancer (IARC) recently reevaluated
TCDD (6-7) and classified it as a Group
1 substance, i.e., carcinogenic to humans.
This evaluation was based on studies con-
ducted over the past 10 years in addition
to broad knowledge on the mechanistic
action ofTCDD. However, a quantitative
assessment of cancer risk associated with
TCDD is difficult because the observed
relative risks (RR) are low even in highly
exposed occupational groups, potential
confounding factors could not always be
taken into account, and quantitative expo-
sure assessment was not always possible.
TCDD accumulates in the body fat with a
half-life ofabout 7 years (8,9). Other con-
geners showed half-lives ranging from 3.0
years (1,2,3,4,6,7,8-heptachlorodibenzofu-
ran) up to 19.6 years (2,3,4,7,8-pen-
tachlorodibenzofuran). Dioxins and furans
therefore are among the few substances for
which the past exposures can be assessed
accurately even decades after exposure,
making quantitative risk assessment
more promising.
In this paperwe describe a dose-response
analysis for total cancer mortality and
TCDD and toxic equivalency [a weighted
sum of dioxins and furans; (7)] exposure
based on a highly exposed occupational
cohort from Germany, which has been
studied previously (3,4,10). We know that
risk assessment for dioxins is a complex
issue that must take into account several
lines ofscientific research. The purpose of
this paper is to use an epidemiologic data
set, among the best available, to derive a
quantitative estimate of cancer risk from
human data.
Material and Methods
CohortDescription
The cohort studied consists of all
1189 regular male employees at the
Boehringer chemical plant in Hamburg,
Germany, that were employed for at least
3 months in the production period
between 1952 and 1984. Exposure to
polychlorinated dibenzo-p-dioxins/furans
(PCDDs/Fs) in the plant occurred in the
production of different herbicides and
insecticides, as described in detail in
Kauppinen et al. (11) and Manz et al.
(10). A mortality follow-up was per-
formed until 31 December 1992. Details
can be found in Manz et al. (10) and
Flesch-Janys et al. (3).
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ExposureAssessment
andDoseVariable
Exposure was verified by PCDD/F and
beta-hexachlorocyclohexane (P-HCH)
measurements in a sample of275 workers.
The mean TCDD was 101.3 nglkg (range
2-2252 nglkg). Half-life was estimated for
all congeners using 48 individuals with
multiple measurements, as described in
Flesch-Janys et al. (8). These results were
then used to backcalculate PCDD/F con-
centration at the end of each worker's
employment, taking into account the
covariables (age and percent body fat). A
regression model was then applied to esti-
mate the dose rates for each congener for
different occupations within the factory.
This procedure is described in Flesch-Janys
et al. (12) and led to dose-rate estimates
that allow estimation ofthe PCDD/F con-
centration, y(t), from beginning of
employment until end offollow-up for
each member ofthe cohort using employ-
ment history data. Based on these concen-
tration curves, we investigated different
methods ofconstructing a dose variable.
Although Flesch-Janys et al. (3) used the
estimated concentration at the end of
employment as a fixed covariable, we
focused our analysis primarily on the
cumulated dose (also called integrated dose
or area under the curve ([AUC]) as a time-
dependent dose variable. This approach
requires much more computation; how-
ever, according Aylward et al. (13), "the
appropriateness of the AUC for under-
standing the effects ofdrugs and chemicals
that act through a receptor-mediated
mechanism has been noted in pharmacol-
ogy tests." There is strong evidence that
TCDD acts through binding to the aryl
hydrocarbon receptor (7). The AUC can
be converted to the lifetime average daily
(or yearly) dose. Table 1 shows the relation
between lifetime average yearly dose (dose
rate), the associated blood level (concentra-
tion), and the AUC, assuming a lifetime of
70 years forselected doses.
For example, a constant intake of
1 ng/kg body weight/year yields a con-
centration of approximately 10 ng/kg
body weight at age 70 and an AUC
value ofapproximately 600 ng/kg body
weightxyears.
Choice ofEndPoints
Standardized mortality ratio (SMR) results
ofthe mortality follow-up are described in
Flesch-Janys et al. (12). Ofprimary interest
for possible dose-response analysis were
those cancers for which a significantly
increased risk was observed for the total
cohort and the number of deaths was
sufficiently large to allow a dose-response
analysis. For example, we had to exclude
lymphosarcoma from our analysis because
the significantly increased SMR of373 was
based on only 5 cases. We therefore decided
to base our dose-response analysis on total
cancer mortality (124 cases; SMR 141; 95%
confidence interval [CI] 117-168) and lung
cancer mortality (38 cases; SMR 151; 95%
CI 107-208). As will be discussed later, the
main focus ofthe analysis lies on the total
cancer mortality. This decision was sup-
ported by the fact that the IARC evaluation
was also based on total cancer mortality,
which has consistently increased in all occu-
pational cohorts with high TCDD expo-
sure, whereas the results are somewhat
inconsistent forspecific cancersites.
Statistical Models
All analyses are based either on the disease
end points total cancer or lung cancer.
Poisson and Cox regression models with
time-dependent covariables were used to
investigate dose-response relationships
between these disease end points and
exposure levels ofTCDD andTEQ (14).
For Poisson regression, an age (four
levels) xcalendar period (seven levels) x
exposure level classification (10 levels,
TCDD or TEQ) was performed. Expected
number ofdeaths and person-years worked
were calculated using West Germany mor-
tality rates with the Fortran program
"Person-Years" (15). Both models were
applied with internal comparison (offset:
person-years) and external comparison (off-
set: expected number of deaths). The
TCDD and TEQ levels within each cell was
Table 1. Relationship between dose rate, concentration, and cumulative dose(AUC) forTCDD.
Constant dose rate, Concentration at Cumulative dose at age 70
ng/kg/year age 70, ng/kg ng/kgxyears pg/kgxyears
0.35 4 240 0.24
1 10 600 0.6
10 100 6000 6
20 200 12,000 12
100 1000 60,000 60
taken as the geometric mean ofcell limits
and entered the Poisson model as a continu-
ous covariable. As exposure variables in the
Cox model we used the cumulated dose
(AUC) ofTCDD,TEQ, andTEQwithout
TCDD (other congeners [TEQ_O]). For
TCDD, it was calculated as
D(t) =Jy(r)dr,
0
wherey(r) denotes the concentration of
TCDD at time r and D(t) denotes the
cumulated dose up to time t. The proce-
dure to estimatey(t) is given in Flesch-
Janys et al. (12). For TEQ the dose was
calculated as
1TEFiXDi(t),
i
where the sum is over all congeners i and
TEFi is the toxic equivalence factor for
congener i. Exposure variables were consid-
ered both separately and simultaneously
within a model whereapplicable. Toadjust
for the coexposure to ,-HCH, an estimate
of the AUC dose for this substance was
used in the Cox model. A mean back-
ground level for the German population of
3.4 ng/kg blood fat TCDD was taken into
account (16-18). As further covariables we
used age at employment entry, year of
entry, and duration ofemployment. The
following categories were used: years ofage
at entry (four categories: <20, <20 to
<30, <30 to <40, and >40); year ofentry
(three categories: before 1 January 1954, 1
January 1954-31 December 1965, and
after 1 January 1966); year ofbirth (six cat-
egories: < 1900, 1900 to< 1910, 1910
to < 1920, 1920 to < 1930, 1930 to<1940,
and after 1940). An unexposed cohort (gas
workers) described in Berger and Manz
(19) was used for internal comparisons in
most analyses. In these analyses an addi-
tional indicator was added into the model.
The model may then begiven as
Ait) = o(t)exp(f3'f(x)),
where xis a vector ofcovariables andfis an
arbitrary function. Assuming apossible dif-
ferent baseline hazard function for different
birth cohorts k, )wk(t), we use the model
Ak(t) = 0Ok(t) Xexp(f(x)),
which can be fitted by defining different
strata through the birth year, which we
grouped as given above. This model is
more flexible and also needs considerably
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less computer time, as the risk sets are
much smaller. We therefore focused
primarily on this model.
Dose-ResponseModeling
Let Xbe the exposure variable ofinterest.
From the Cox model the RR function
RR(x)=exp(f(x)f)
can be derived. For modeling dose
response, we investigated different shapes
ofthe dose-response curve. A convenient
method for defining a general model in
which a linear relative risk function as well
as concave and convex risk functions are
covered is as follows. Letfbe a transforma-
tive ofthe exposure variable with
fJx)=log(kx+ 1),
kconstant. Then we have
RR(x,3) =exp(/3log(kx+ i)P
The value of/Bdepends on k. For ,B< 1 the
dose-response curve is concave; for /3> 1 it
is convex. The model is therefore flexible
enough to allow a rich set ofmonotone RR
functions. Ifkis chosen such thatP= 1, an
additive (linear) dose-response curve is
obtained. The best model is obtained by
evaluating the goodness-of-fit statistic
(deviance). A statistical evaluation ofthe
method is given in Becher et al. (20).
Latency
Latency forcancer varies from a fewyears to
several decades. Different methods are avail-
able to address latency in epidemiologic
studies (21). Here we chose to consider
lagged exposure as
t-k
D(t)= Jy(t)dt,
0
k=0, 5, 10, 15, or 20 years, where y(t)
denotes concentration at time t. With this
definition, the last k years ofexposure are
not considered. This procedure "has the
particular advantage ofincluding the entire
enumerated cohort and all members'
complete exposure histories" (21).
AttributableandAbsolute
RiskEstimaton
The dose-response functions can be used
to estimate the impact for a population
with a given background level. Both the
absolute risk for a given (unit) level and the
attributable risk (AR) can be estimated.
The attributable riskforTCDD exposure is
AR P(D= 1)-P(D= 1ITCDD=0)
P(D=1)
=1- ~~~~1 fRR(TCDD)f(TCDD)
wherefis thedensityofTCDD distribution
in thepopulation. This formulareduces to
AR= RR-i
RR
if the RR function is linear in the dose
range observed in the population, where
RR is that for the mean exposure level of
TCDD in the population. Information on
background exposure to TCDD, TEQ,
and ,-HCH and resulting blood levels in
Germany (16-18) were used for calcula-
tion. The attributable risk is given for the
accumulated dose at age 70 under back-
ground exposure, which is approximately
240 ng/kgxyears (Table 1).
For absolute risk estimation we consider
the absolute additional cancer risk associ-
ated with a constant exposure to a prede-
fined dose, known as the unit risk (UR). It
is defined as UR=P(disease lifelong con-
stant exposure ofunit dose)-P(disease no
exposure). This quantity may be estimated
using background mortality rates and the
derived RR function (20). Here we use the
German rates for total cancer mortality and
total mortality (22). In accordance with
previous risk assessments, we use the daily
dose 1 pg/kg body weight/day as the unit.
Assuming a body fat proportion of25%
this daily dose corresponds to 4 pg/kg
fat/day or 365 x4= 1.46 ng/kg fat/year.
According to Table 1 this yields a cumula-
tive dose of 869 ng/kg fatxyears after a
70-year exposure to TCDD.
To calculate the UR based on ambient
air exposure, we need additional considera-
tions. Assuming a daily respiratory volume
of20 m3 and absorption of 50% (20), we
get an intake of 10 pg/day from a unit
ambient air concentration level of 1 pg/m3,
i.e., 0.14 pg/kg bodyweight/day (assuming
a mean body weight of70 kg). This corre-
sponds to 0.56 pg/kg fat/day=0.204 ng/kg
fat/year and equals 14% ofthe unit value
obtained from an intake of 1 pg/kg body
weight/day.
We used the SAS software package for
all calculations. Cox regression models
were fitted using PROC PHREG. The
software package EGRET was used for
Poisson regression (23).
Results
As shown in Flesch-Janys et al. (12), SMR
analyses yielded significantly increased
overall SMR for all cancers and lung cancer
in the total cohort (SMR 1.41; 95% CI
1.17-1.68 and SMR 1.51; 95% CI
1.07-2.08, respectively) and an increasing
SMRwith TCDD and TEQ dose levels. A
dose-response analysis therefore seems
justified. Our results are presented below.
PoissonRegsion
Results ofthe Poisson model are presented
in Table 2. The results with external rates
reflect the observation in Flesch-Janys et al.
Table 2. Results of Poisson regression analysis for TCDD and TEQ, all cancers combined, latency 0 years, with
internal and external German population comparison.
Model X2 df /iGM J3TCDD p-Value, /3TCDD
Internal comparison, offset: person-years
Intercept only(GM) - - -5.52 -
GM +TCDD 10.0 1 -5.62 0.0272 0.001
GM +TCDD + age +calendar period 210.1 9 -8.38 0.0156 0.070
External comparison, offset: expected
number ofdeaths
Intercept only(GM) - - 0.34a -
GM +TCDD 3.3 1 0.27 0.0163 0.055
Internal comparison, offset: person-years
Intercept only(GM) - - -5.52 -
GM +TEQ 11.4 1 -5.67 0.0274 <0.001
GM +TEQ +age +calendar period 208.9 9 -8.38 0.0107 0.175
External comparison, offset: expected
number ofdeaths
Intercept only(GM) - - 0.34a -
GM +TEQ 1.8 1 0.27 0.0109 0.164
Abbreviations: x2, difference of deviances to model with intercept only; df, degrees of freedom; GM, general
mean. "The overall SMR in the cohort is exp(IPGM)=1.40.
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Table 3. Results of Cox regression analyses for TCDD
with categorized exposure levels, latency 0 years, all
cancers combined.
p-Value
TCDD categoriesa RR 95% Cl (PTCDD)
O<TCDD< 1 1.00 - -
1 <TCDD<4 1.12 0.70-1.80 0.63
4<TCDD <8 1.42 0.70-2.85 0.33
8<TCDD< 16 1.77 0.81-3.86 0.15
16<TCDD <64 1.63 0.73-3.64 0.23
64<TCDD 2.19 0.76-6.29 0.15
Results are adjusted for year at entry, age at entry,
duration of employment, and stratified for birth cohort
(p[trend]=0.03). &Measured inpg/kg bloodfatxyears.
(12) in which increasing SMR were
observed with increasing levels ofTCDD
and TEQ exposure. Here TCDD and
TEQwere used as a continuous variable in
the Poisson regression model. Internal
comparison yielded similar results.
CoxRegsion: GeneralModels
A first investigation with the Cox model of
TCDD levels grouped into five categories
yielded the results in Table 3. As in the
SMR analysis, increasing RR was observed
with increasing dose level.
Table 4 lists results of the full Cox
regression model with the all cancers end
point, TCDD, TEQ_O, and f-HCH as
time-dependent continuous exposure
covariables, with all other covariables. This
model yields RR( TCDD) = exp(0.0089
TCDD), TCDD in pg/kgxyears with a p
value of 0.06. Few of the adjustment fac-
tors had separate effects. However, year at
entry before 1954 was associated with a
significantly increased risk (RR= 1.54;
95% CI 1.12-2.09).
Investigation ofTEQ levels grouped
into five categories yielded results similar to
those for TCDD; however, there was a
somewhat less pronounced increase in risk
with increasing dose levels (Table 5).
Table 5. Results of time-dependent Cox regression
analyses for TEQ with categorized exposure levels,
latency 0 years, all cancers combined.
p-Value
TCDD categoriesa RR 95% Cl (PTCDD)
0OTEQ<4 1.00 - -
4.TEQ<8 0.99 0.59-1.68 0.98
8<TEQ< 12 1.40 0.70-2.77 0.34
12<TEQ<20 1.35 0.63-2.84 0.44
20<TEQ<80 1.68 0.81-3.48 0.16
80<TEQ 2.08 0.61-7.03 0.23
Results are adjusted for year at entry, age at entry,
duration of employment, and stratified for birth cohort
(p[trend]= 0.06). &Measured in pg/kg blood fat xyears.
Table 4. Results of Cox regression analyses for TCDD, exponential risk function, latency 0 years, all cancers
combined.
Variable Parameter estimate Standard error p-Value RR
TCDD, pg/kgxyears 0.0089 0.0047 0.058 1.01
TEQ_0 -0.024 0.06 0.70 0.98
)-HCH 0.14 0.10 0.17 1.15
Cohort, gasworkers vs Boehringer 0.11 0.22 0.63 1.11
chemical plantworkers
Duration ofemployment, years
<1 -0.063 0.30 0.83 0.94
<1 <3 0.43 0.26 0.10 1.53
.3 < 10 Baseline - - 1.0
. 10 -0.25 0.19 0.18 0.78
Age atentry, years
<20 0.27 0.21 0.19 1.32
<20 <30 Baseline - - 1.0
<30 <40 0.086 0.14 0.54 1.09
>40 0.10 0.17 0.54 1.11
Calendaryearat entry
Before 1 January 1954 0.43 0.16 0.008 1.53
1 January 1954-1 January 1966 Baseline - - 1.0
After 1 January 1966 0.19 0.23 0.41 1.2
Table 6 lists results ofthe Cox regres- (PTCDD=0.0096; PTEQ=0.01). However,
sion model with the all cancers end point, because the number of cases was much
TEQ and ,B-HCH as time-dependent con- lower, these estimates have low precision
tinuous exposure covariables, and all other and result inp-values of 0.28 and 0.22,
covariables. This model yields RR(TEQJ= respectively. This indicates that the effect
exp(0.0078 TEQ), TEQ in pg/kgxyears ofthe exposures may be similar for lung
with a p-value of0.07. Again, few ofthe cancer and all cancer sites. The degree of
adjustment factors had separate effects. uncertainty appears to be too high, how-
Entry into the plant before 1954 again was ever, to give explicit dose-response func-
associated with a significantly increased risk tions for TCDD or TEQ exposure and
(RR= 1.53; 95% CI 1.12-2.09). Duration lung cancer risk.
ofemployment and age at entry had no
additional effect. Birth cohort effects were Cox R on L Ef s
accounted forin this modelbystratification. Table 7 shows the results ofthe investiga-
Analysis for lung cancer using either tion of possible latency effect on total
TCDD or TEQ as the exposure variable cancer mortality. The regression coeffi-
yielded almost the same regression esti- cients for TCDD and TEQ, the associ-
mates as that for the total cancer analysis ated p-values, and the goodness-of-fit
Table 6. Results of Cox regression analyses for TCDD, exponential risk function, latency 0 years, all cancers
combined.
Variable Parameterestimate Standard error p-Value RR
TEQ, pg/kgxyears 0.0078 0.0042 0.066 1.01
1-HCH 0.109 0.086 0.20 1.12
Cohort, gas workers vs Boehringer -0.07 0.21 0.74 0.93
chemical plantworkers
Duration ofemployment, years
<1 -0.04 0.30 0.89 0.96
<.1 <3 0.45 0.26 0.08 1.57
<3<'10 Baseline 1.0
2 10 -0.27 0.18 0.15 0.77
Age atentry, years
<20 0.27 0.21 0.19 1.31
<20 <30 Baseline - 1.0
<30 <40 0.09 0.14 0.53 1.09
>40 0.10 0.17 0.56 1.10
Calendaryearatentry
Before 1 January 1954 0.42 0.16 0.008 1.52
1 January 1954-1 January 1966 Baseline 1.0
After 1 January 1966 0.20 0.23 0.40 1.22
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Table 7. Influence of latency on different models for
TCDD and TEQ.
TCDD TEQ
Latency, p-Value, P-Value,
years PTCDD PTCDD oo TEO PITEO
0 0.0096 0.026 0.0093 0.024
5 0.0104 0.023 0.0101 0.020
10 0.0116 0.021 0.0113 0.018
15 0.0132 0.020 0.0130 0.017
20 0.0160 0.021 0.0157 0.018
Results are adjusted for year at entry, age at entry,
duration ofemployment, and stratified for birth cohort.
statistic for the total model are given. The
regression coefficients gradually increase
with increasing latency time. There is a
slight improvement of the fit with
increased latency time, but the p-values
for PTCDD and J3TEQ remain almost con-
stant. It is noteworthy that for the estima-
tion of the lifetime risk the choice ofthe
latency period has little effect because the
smaller dose associated with a longer
latency period is outweighed by the larger
regression coefficient.
CoxRegs ion:
Dose-ResponseModeling
Most emphasis was placed on assessing the
dose-response curve. We investigated the
class ofmodels RR(x,f) =exp(,B log(kx= 1))
=(kx+ 1)fiusing the deviance as measure for
goodness offit. In these models, log(kx+ 1)
is the transformation function for the dose
variable and ,B is the estimated parameter.
Values for k were chosen arbitrarily. Figure
1 compares deviation and k for the Cox
model, with TCDD as the exposure vari-
able and all other variables used as covari-
ables as before. The maximum ofthe curve
is the model with the best fit to the data
among the class of RR functions consid-
ered. Figure 2 shows corresponding results
with a latency of 10 years. Table 8 gives the
results ofthree selected models: the model
with the best fit, the additive RR function,
and the exponential RR function, all with
latency times of 0 and 10 years.
The differences in respective fits are
small; therefore we cannot justify selection
of a particular model on statistical grounds.
The model with the best fit has a concave
shape and therefore yields higher risks for
low exposures. The dose-response curves
are displayed in Figure 3.
The same procedure was applied for
TEQ. Again, the differences in goodness of
fit were small. In this case, the model with
the best fit is rather close to the additive
RR function. Results of the analysis are
given in Table 8 and the dose-response
curves are displayed in Figure 4.
Attributable Risk
andUnitRisk Esimate
Because the dose-response analysis yielded
stronger results for TCDD than for TEQ,
and because there was no indication of a
separate effect of congeners other than
TCDD in either the present cohort or in
other epidemiologic studies, we present
attributable risk and UR estimates for
TCDD only. As shown previously, based
on the data, no clear distinction can be
made as to the function on which absolute
risk estimation should be based. Under
the additive RR function we estimate an
attributable risk of 0.0038 (95% CI
0.0004-0.007) for TCDD assuming a
constant dose rate of0.35 ng/kg/year.
UR estimates both for a unit intake of
1 pg/kg body weight/day and a unit con-
centration value of 1 pg/m3 in ambient air
are given in Table 9. For the unit intake 1
pg/kg body weight/day these values range
from 1.2x 10-3 to 7.7x 10-3. For the unit
immission value of 1 pg/m3, values rang-
ing from 1.65 x 10- to 1.1 x 10-3 are
observed. These ranges reflect the degree
ofvariation associated with the respective
models; they are not interpretable as
confidence intervals.
Discussion
We have presented an extensive analysis of
a single cohort ofworkers with high expo-
sure to TCDD and other higher chlori-
nated dioxins and furans. This cohort is
among the most studied dioxin-exposed
cohorts in the world. Nevertheless, there
are several limitations to this type ofanalysis
and these are discussed below.
* Additive model, P
= 1
* Multiplicative model
* Additive model, ,B = 1
Multiplicative model
0.2 0.4 0.6 0.8
k
Figure 2. Goodness of fit for different RR models of
the form RR(x,/)3=(kx+ 1)P for TED (latency=0 years).
Table 8. Results of different dose-response models forTCDD andTEQ, in pg/kg blood fat.
likelihood
ratio p-Value
Model Relative riskequation Estimate statistic of ,B
TCDD
latencytime: 0 years
Multiplicative model RR(x)=exp(f3x)) /=0.00869 30.2 0.043
Additive model RR(x)=1 +fx) /=0.016 30.8 0.031
Powermodel RR(x)=exp(/3 log(kx+1))(kx+1) /=0.326, k=0.17 31.2 0.026
Model withoutTCDD 26.9 -
Latencytime: 10years
Multiplicative model RR(x)=exp(/3x)) /=0.0098 34.0 0.048
Additive model RR(x)= 1 +/3x) /3=0.018 34.4 0.038
Powermodel RR(x)=exp(/ log(kx+11))=(kx+1) /=0.398, k=0.11 34.6 0.036
Model withoutTCDD 30.9 -
TEQ
Latencytime: 0years
Multiplicative model RR(x)=exp(/3x)) /3=0.00853 30.2 0.045
Additive model RR(x)=1 +fix) p=0.015 30.5 0.040
Power model RR(x)=explplog(kx+1))=(kx+1)p /=0.7847, k=0.023 30.5 0.040
Model withoutTEQ 26.9 -
Latencytime: 10years
Multiplicative model RR(x)=exp(l/x)) /=0.00946 34.0 0.049
Additive model RR(x)= 1 +fix) /=0.0175 34.2 0.045
Power model RR(x)=exp(plog(kx+1))=(kx+1)p =0.8754, k=0.022 34.2 0.045
Model withoutTE - 30.9 -
Results are adjusted foryear at entry, age at entry, duration ofemployment, P-HCH, and stratified for birth cohort.
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Figure 1. Goodness offit for different RR models ofthe
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20,000 40,000 60,000 80,000 100,000
TCDD, ng/kg blood fatxyears
Table 9. Unit risk estimations forTCDD using different
models and latencytimes.
- ---RRIxI = explo.00000869x1
RRIx) = 1 + 0.000016x
- RxI=exp(0.326xIlog(0.00017x+ 1))
120,000 140,000 160,000
Figure 3. Estimated dose-response model of the categorical and continuous models for TCDD (latency time=
0years).
----- RR(xM =exp(0.000008353x1
RR(x = 1 + 0.000015x
- RR(x) = explO.784738 x log(0.000023x + 1
60,000 80,000 100,000
TEQ, ng/kg blood fat x years
Figure 4. Estimated dose-response model of the categorical and continuous
0 years).
Magnitude ofEffectand
Assessment ofDose
The overall effect of exposure to cancer risk
was not very large, and it was therefore
unlikely that a dear picture ofthe shape of
the dose-response curve could emerge.
This cohort, however, was unique in that
exposure assessment based on blood mea-
surements was available for many cohort
members. We have shown that the work
histories can be used to estimate concentra-
tions of substances during exposure and
after exposure has ceased, and therefore we
were able to get sufficiently reliable esti-
mates for the exposures ofall cohort mem-
bers (12). Nevertheless, there are several
sources of variation within this estimation
procedure. These, however, are not likely
to be related to cause ofdeath and there-
fore would yield underestimations rather
than overestimations ofthe effect.
Robustness of Ri
Additional anal)
investigate the rn
Because categorizia
is always arbitrary,
procedures, for ex.
categories. All mo
and without the
unexposed contrc
differences were
however, the star
what higher whe
exduded. We pern
using the year o
divide the cohort
We used the upp
limit to estimate 1
obtained from Fl
dose calculation
from specific pr
because they ma
Unit
Latencytime, ambient air
model Unit intakea concentrationb
0 years
Additive 2.5x10-3(m) 3.5x104( m)
2.1 x10-3(f) 3.0x109(f)
2.3x10-3(t) 3.25x10-4(t)
Multiplicative 1.4x10-3(m) 1.9x 10 (m)
1.2x103 (f) 1.6x104(f)
1.3x10-3(t) 1.75x'I0 4 (t)
Power 8.4x103(m) 1.2x10-3(m)
7.0x103(f) 1.Ox 10-3(f)
7.7x10-3(t) 1.1 X1(-3 t)
10years
Additive 2.4x103(m) 3.3x104 o(m)
2.0x10-3(f) 2.8x104(f)
2.2x10-3(t) 3.05x104(t)
Multiplicative 1.3x103(m) 1.8x10 (m)
1.1 X1-3(f) 1.5x104 4(f)
1.2x10-3(t) 1.65x10oAIt)
Power 5.6x10-3 (m) 8.0x104(m)
4.7x10-3(f) 6.8x104(f)
5.15x10-3(t) 7.4x104(t)
Abbreviations: f, females; m, males; t, total. '1 pg/kg
bodyweight/day. b1 pg/m3.
00 ,other substances (e.g., lindane). A possible
effect for using the unexposed comparison
cohort was investigated by omitting it from
the dataset. All these analyses yielded only
slight changes in the overall results. This
was true for both TCDD and TEQ as the
dose variable. Using exposure to P-HCH
as an additional covariable did not alter the
120,000 140,000 160,000 risk estimates forTCDD orTEQ. In some
analyses P-HCH showed an independent
effect; however, this finding needs further
investigation. A full account ofthe results
from these analyses are given in the technical
report ofthis study.
The observed effect of the variable year
yses were performed to ofentrybefore 1954 is difficult to interpret.
Dbustness of the results. This effect holds for both cohorts, which
ng continuous covariables indicates that it is independent ofTCDD
, we investigated different exposure. However, the possibility cannot
ample, using more refined be excluded that exposure before that date
dels were calculated with actually was higher than predicted by our
gas worker cohort as an models. Duration ofemployment and age
)l cohort. No substantial at entry had no additional effects. Birth
1bserved in the estimates; cohort effects were accounted for in this
ndard errors were some- model by stratification (see "Materials and
n the gas workers were Methods"). Using birth cohort as a covari-
formed subgroup analyses able yielded almost identical results (data
tf employment entry to not shown).
into different subcohorts.
er and lower confidence
the half-life ofTCDD as
lesch-Janys et al. (8) for
. We excluded workers
*oduction departments
.y have been exposed to
Threshold versusNontbreshold Lev
Some authors [e.g. Aylward et al. (13)]
consider the possible existence of a thresh-
old level for TCDD. It is almost impossible
to obtain conclusions concerning a possible
threshold level from epidemiologic data.
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The fact that the dose-response curve with
the best fit has a concave shape may be
interpreted as an indication ofthe absence
of a threshold. A similar dose-response
curve has been reported very often. One
example is cumulative dose of inhaled
arsenic and lung cancer for which Enterline
et al. (25) found a similar dose-response
curve. In this study, cumulative exposure as
air concentration xtime of exposure was
used as a dose variable. Arsenic, however, is
rapidly excreted from the body, and there-
fore this dose variable may be considered
the AUC with a very low half-life in the
body. A direct comparison ofthe results is
therefore not possible. Both the kinetics of
these two substances and the suspected
mechanism in cancer development are dif-
ferent. The data from this study do not
indicate the existence ofa threshold level.
However, no definite conclusions can be
drawn on that issue from these data.
DioxinandOtherAirPollutants
Cancer risks from seven ambient air pollu-
tants (arsenic, asbestos, cadmium, diesel
exhaust, polycyclic aromatic hydrocarbons,
TCDD, benzene) have been estimated and
compared for Germany (26). In this study
the additional lifetime cancer risk from
constant exposure to 1 ng TCDD/m3 in
ambient air was given as 1.4x 10-3 based
on animal data. Our estimated values range
from 3x 10-4 to 3x 10-3, slightly lower
but in the same order of magnitude.
Taking the absolute concentration of
TCDD in the ambient air into account, in
the range 1 to 10 fg/m3, it is reasonable to
suggest that the cancer risk from ambient
air TCDD concentration is very low and
almost negligible. In the LAI report (26) it
was concluded that the relative importance
ofTCDD in relation to other air pollu-
tants is very low, a statement that can be
made with a somewhat larger degree of
certainty based on our results.
EffectofDifferentCongeners
A separate effect for other PCDD/Fs other
than TCDD could not be established. This
was partly because exposure was highly cor-
related with P-HCH exposure. Although
in the dose-response analysis we observed a
relationship between cancer risk and both
TCDD and TEQ exposure, we feel less
confident about the result for TEQ. The
dose-response curve for TCDD is similar
to that for TEQ, as seen in Table 7. The
background level ofTEQ is about 5 to 10
times larger than that of TCDD and
absolute risks could easily be calculated.
However, because no separate effects for
dioxins other than TCDD were identified
in this or any other occupational cohort,
we did not present URs forTEQ.
ChildhoodExposur
It must be noted that with our data it is
not possible to address the effect ofdioxin
exposure in childhood. Although it is
likely that metabolism at younger ages
yields a shorter half-life for dioxins, data
on adverse health effects, in particular
cancer development later in life, are not
available and cannot be deduced. It is
possible that such effects may become visi-
ble after a long-time observation time of
Seveso, Italy, cohort (27). One cannot
exclude the possibility that exposure to
TCDD in early childhood poses a higher
risk than predicted from the models given
here. Although it is possible to employ
some safety factors for childhood exposure
levels to address this fact, such factors
must be arbitrary and would not be based
on scientific knowledge.
DoseMetricandLatency
The question ofthe appropriate dose metric
is difficult to answer. In previous analyses
with this cohort, concentration at end of
employment was used. This analysis also
demonstrated a positive relationship to
cancer. There is no clear supporting evi-
dence for a specific dose metric; however,
for environmental risk assessment it appears
that cumulative dose is accepted as an
appropriate metric. The results on latency
are interesting. In terms of absolute risk
estimates, the results are almost identical for
any latency period used. This is because the
increasing regression coefficient with
increasing latency time is outweighed by
decreasing cumulative dose with latency.
Therefore, the question ofthe true latency
is of less importance for quantitative
risk assessment.
OtherRiskAssessments
The U.S. Environmental ProtectionAgency
currently is performing quantitative risk
assessment for TCDD based on published
data from three occupational cohort
studies (1,10,28). No dose-response
analyses using individual data are per-
formed. These results were available only
in a draft version at the time this paper
was written and therefore were not avail-
able for comparison with our results. In
general, analyses based on tabulated sum-
mary data are less precise than those based
on individual measurements. In addition,
it is not possible to adjust for potential
confounders. On the other hand, analyses
based on such grouped data may be more
robust because extreme data points may
have less impact.
In summary, our risk assessment is
based on an occupational cohort with a
large number ofindividual dioxin measure-
ments. The result, which was not included
in the IARC evaluation because it was not
published at that time, supports the recent
dassification ofTCDD as an IARC Group
1 substance. The estimated risks at envi-
ronmental levels are on the same order of
magnitude as those obtained from previous
animal experiments using a linearized mul-
tistage model. Several assumptions were
made to bridge data gaps that hampered
interpretation of the findings. Thus, all
results should be considered with caution,
as the risk levels in the low-dose range are
strongly dependent on the underlying
model and the appropriateness of the
underlying assumptions. This study is not
a final risk estimate for dioxins but we
believe that it contributes a relevant body
of information that might help solve the
dioxin-cancer puzzle.
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